Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
StarTric logo — Transcatether Tricuspid Valve Repair

StarTric

Transcatether Tricuspid Valve Repair

Italy Italy 2 employees Seed Manufacturing, Medical Devices

General Information

Company Name StarTric
Location Italy Italy +1
Employees 2
Industries Manufacturing, Medical Devices
Funding Stage Seed
Social

Get notified when StarTric moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About StarTric

StarTric is an Italian startup that is developing an innovative structural heart technology to treat the regurgitation of the tricuspid valve. The company's slogan "Transcatheter Tricuspid Valve Repair" highlights its focus. Founded by Prof. Ottavio Alfieri and Prof. Michele De Bonis, the company's transcatheter device aims to replicate the results of the Clover repair, a highly effective open surgery technique. With a focus on addressing tricuspid regurgitation, which affects a significant portion of the population, StarTric is positioned as a pioneer in next-generation technologies for tricuspid valve treatment. The company has received a Seed Round investment from Growth Engine and NLC in July 2024, indicating investor confidence in the startup's potential. Despite being still in development, StarTric's approach holds promise for addressing a critical cardiovascular condition and has the potential to make a substantial impact in the medical devices and manufacturing industries.

Taxonomy: structural heart technology, transcatheter tricuspid valve repair, minimally invasive device, cardiovascular disease treatment, transcatheter repair implantable device, professor-led innovation, tricuspid regurgitation, edge-to-edge repair technique, cardiac surgery, tricuspid valve, heart failure treatment, atrial fibrillation, medical device innovation, personalized healthcare, clinical device development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor
•••• •••• 		08 Jul 2024

StarTric Alternatives & Competitors

StarTric vs
Mitralign Inc.
Mitralign Inc. United States

Mitralign, Inc. is the valve repair company with the only direct transcatheter annuloplasty system d...

Series Unknown
2 employees
Health Care, Medical Devices

FAQ About StarTric

Transcatether Tricuspid Valve Repair
StarTric is headquartered in Italy.
StarTric operates in the following industries: Manufacturing, Medical Devices.
StarTric has approximately 2 employees.
StarTric has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to StarTric include Mitralign Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
StarTric and Mitralign Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors StarTric and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy